Overview
- The market frames a direct choice between newly public SpaceX, which trades at an outsized market cap near $2 trillion, and Rocket Lab, which has a market value around $60–62 billion and a much lower entry price.
- Mid‑June analyst moves raised institutional interest in Rocket Lab, with KeyBanc upgrading the shares and KGI initiating coverage, signaling fresh research coverage and buy-side attention.
- Rocket Lab reports far smaller losses than SpaceX, with roughly $183 million in trailing 12‑month losses and a revenue multiple near 80x versus SpaceX’s substantially higher multiple and larger quarterly losses.
- Near‑term market catalysts support Rocket Lab’s case: record revenue and backlog, planned Nasdaq‑100 inclusion that forces mechanical buying, and steady NASA activity that limits launch capacity.
- Investors should watch Rocket Lab’s dilution risks from its ATM facility and the pace of Neutron development while weighing SpaceX’s scale, Starlink and space‑AI plans alongside its heavy cash burn and execution risk.